{"disease":{"id":"pulmonary-fibrosis","name":"pulmonary fibrosis"},"drugs":{"marketed":[{"drug_id":"nintedanib","indication_name":"Idiopathic pulmonary fibrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ofev","generic_name":"NINTEDANIB","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Receptor-type tyrosine-protein kinase FLT3","drug_class":"Kinase Inhibitor","quality_score":70,"revenue":"2000","mechanism":"Ofev works by blocking enzymes that promote fibrosis and tumor growth."},{"drug_id":"ofev","indication_name":"Idiopathic pulmonary fibrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OFEV®","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Calcium/calmodulin-dependent protein kinase type IV, Cyclin-dependent kinase 18, Cyclin-dependent kinase-like 2","drug_class":"Kinase Inhibitor","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"nerandomilast","indication_name":"Idiopathic Pulmonary Fibrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jascayd","generic_name":"NERANDOMILAST","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Jascayd works by inhibiting the activity of phosphodiesterase 4, an enzyme involved in the inflammatory response."},{"drug_id":"nerandomilast","indication_name":"Progressive Pulmonary Fibrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jascayd","generic_name":"NERANDOMILAST","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Jascayd works by inhibiting the activity of phosphodiesterase 4, an enzyme involved in the inflammatory response."},{"drug_id":"vargatef","indication_name":"Idiopathic pulmonary fibrosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"vargatef","company_name":"ARCAGY/ GINECO GROUP","drug_phase":"discontinued","molecular_target":"Calcium/calmodulin-dependent protein kinase type IV, Cyclin-dependent kinase 18, Cyclin-dependent kinase-like 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT03958071","title":"A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking","phase":"","overall_status":"COMPLETED","enrollment_count":13264,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT06485635","title":"Real-life-persistence to Antifibrotic Treatments","phase":"","overall_status":"COMPLETED","enrollment_count":10646,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT02607722","title":"All-Case Surveillance of Ofev in Patients With IPF in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":10117,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT05382572","title":"Pulmonary Fibrosis Foundation Community Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Pulmonary Fibrosis Foundation","has_results":false},{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT00001532","title":"Role of Genetic Factors in the Development of Lung Disease","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07178392","title":"Disease-syndrome Characteristics of IPF","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2864,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT05779007","title":"Dose Reduction and Discontinuation With Anti-Fibrotic Medications","phase":"","overall_status":"COMPLETED","enrollment_count":2778,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT04896138","title":"University of Virginia Natural History Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT07441408","title":"Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":2277,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT02758808","title":"Pulmonary Fibrosis Foundation Patient Registry","phase":"","overall_status":"COMPLETED","enrollment_count":2004,"lead_sponsor_name":"Pulmonary Fibrosis Foundation","has_results":false},{"nct_id":"NCT04930289","title":"Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Paragonix Technologies","has_results":false},{"nct_id":"NCT05022784","title":"Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1798,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT05870956","title":"Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1798,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT06238622","title":"A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1700,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT03120481","title":"Controls for Respiratory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1572,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05337163","title":"A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China","phase":"","overall_status":"COMPLETED","enrollment_count":1564,"lead_sponsor_name":"Creative Biosciences (Guangzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06685874","title":"Interstitial Lung Disease Exacerbations Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Royal Devon and Exeter NHS Foundation Trust","has_results":false},{"nct_id":"NCT06003426","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1255,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT05321069","title":"A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1177,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT06025578","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1057,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT02699879","title":"Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)","phase":"","overall_status":"COMPLETED","enrollment_count":1009,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT03478553","title":"The Genetics of Pulmonary Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05392881","title":"Interstitial Lung Disease Research Unit Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT05842681","title":"Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07404423","title":"OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Modena and Reggio Emilia","has_results":false},{"nct_id":"NCT07162870","title":"Idiopathic Pulmonary Fibrosis Cohort of TCM","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03211507","title":"Idiopathic Pulmonary Fibrosis Job Exposures Study","phase":"","overall_status":"COMPLETED","enrollment_count":960,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT04016168","title":"Idiopathic Pulmonary Fibrosis and Serum Bank","phase":"","overall_status":"COMPLETED","enrollment_count":903,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04564183","title":"Advancing Prevention of Pulmonary Fibrosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04016181","title":"The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":800,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT03666234","title":"Idiopathic Pulmonary Fibrosis Registry China Study","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Dai Huaping","has_results":false},{"nct_id":"NCT07520110","title":"Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT03733444","title":"A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":781,"lead_sponsor_name":"Galapagos NV","has_results":true},{"nct_id":"NCT01619085","title":"Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":752,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT03437486","title":"Mechanisms of Familial Pulmonary Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06457269","title":"Evaluating the Potential of Large Language Models for Respiratory Disease Consultations","phase":"NA","overall_status":"COMPLETED","enrollment_count":703,"lead_sponsor_name":"North Sichuan Medical College","has_results":false},{"nct_id":"NCT05028894","title":"23andMe IPF Research Study","phase":"","overall_status":"COMPLETED","enrollment_count":690,"lead_sponsor_name":"23andMe, Inc.","has_results":false},{"nct_id":"NCT04552899","title":"A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":665,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06521125","title":"Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04680832","title":"Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04708782","title":"Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":598,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT05255991","title":"Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":597,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT04263727","title":"A Study of Patients With Chronic Disease","phase":"","overall_status":"TERMINATED","enrollment_count":579,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT03732859","title":"PROOF-Registry New and Extended Belgium -Luxembourg","phase":"","overall_status":"COMPLETED","enrollment_count":575,"lead_sponsor_name":"Belgian Thoracic Society","has_results":false},{"nct_id":"NCT01769196","title":"Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":544,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03711162","title":"A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":525,"lead_sponsor_name":"Galapagos NV","has_results":true},{"nct_id":"NCT02759120","title":"CleanUP IPF for the Pulmonary Trials Cooperative","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":513,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT07464912","title":"A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":508,"lead_sponsor_name":"Beijing Tide Pharmaceutical Co., Ltd","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}